![]() |
|
|||||||||||||
|
|
![]() |
|
||||||||||||
|
A five year observational study (registry) of children aged two to less than six years at enrollment with transfusional hemosiderosis treated with deferasirox Who can participate?
What does the study involve? Several times a year, a member of the study team will review the medical record and collect information about current drug treatment for iron overload, medical history (including illness and medicines or treatments), transfusion requirements, blood pressure, and growth and development. The results of any eye exams or hearing tests will be collected. Some lab results will also be collected. This is information that is usually recorded at visits to the hospital or clinic. Patients do not have to be seen at CHRCO to participate in this study. The study will reimburse $25 for each completed year. There are no special tests or study visits required. The study does not provide Exjade.For more information, please contact Jacqueline Madden at Children's Hospital & Research Center at Oakland, 510-428-3885, ext. 5745 or ask your clinical care provider. |
||||||||||||||
|
© 2005 Children's Hospital Oakland Research Institute |
||||||||||||||